Laura Kirby

748 total citations
11 papers, 362 citations indexed

About

Laura Kirby is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura Kirby has authored 11 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Kirby's work include Advanced Breast Cancer Therapies (4 papers), Melanoma and MAPK Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Laura Kirby is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Melanoma and MAPK Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Laura Kirby collaborates with scholars based in Australia, United States and Belgium. Laura Kirby's co-authors include Carleen Cullinane, Kelly Waldeck, Grant A. McArthur, Karen E. Sheppard, Rodney J. Hicks, Claire Martin, Richard B. Pearson, Donald P. Cameron, Peter Eu and Richard W. Tothill and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Cancer.

In The Last Decade

Laura Kirby

11 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Kirby Australia	8	245	169	128	49	37	11	362
Woody Han United States	6	141 0.6×	188 1.1×	77 0.6×	18 0.4×	22 0.6×	8	345
Nicole Drezner United States	8	233 1.0×	160 0.9×	218 1.7×	15 0.3×	24 0.6×	13	430
María San Román Spain	11	182 0.7×	130 0.8×	98 0.8×	23 0.5×	12 0.3×	16	343
Mark T. J. van Bussel Netherlands	8	182 0.7×	119 0.7×	165 1.3×	24 0.5×	13 0.4×	11	344
Özge Gümüşay Türkiye	11	164 0.7×	100 0.6×	124 1.0×	33 0.7×	8 0.2×	42	350
Deepa Prabhavalkar United States	2	295 1.2×	228 1.3×	183 1.4×	15 0.3×	13 0.4×	2	477
Adekemi Taylor United States	4	142 0.6×	338 2.0×	100 0.8×	26 0.5×	16 0.4×	17	482
A. Barnadas Spain	10	244 1.0×	179 1.1×	88 0.7×	17 0.3×	26 0.7×	27	419
K. Papadopoulos United States	11	198 0.8×	236 1.4×	136 1.1×	39 0.8×	6 0.2×	46	462

Countries citing papers authored by Laura Kirby

Since Specialization

Citations

This map shows the geographic impact of Laura Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kirby more than expected).

Fields of papers citing papers by Laura Kirby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kirby. The network helps show where Laura Kirby may publish in the future.

Co-authorship network of co-authors of Laura Kirby

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Kirby. A scholar is included among the top collaborators of Laura Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Kirby. Laura Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

MacManus, Michael, Laura Kirby, Benjamin J. Blyth, et al.. (2023). Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC. Clinical and Translational Radiation Oncology. 43. 100682–100682. 4 indexed citations

AbuHammad, Shatha, Alison Slater, Laura Kirby, et al.. (2021). CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway. Cancers. 13(3). 524–524. 16 indexed citations

Lau, Peter K. H., Carleen Cullinane, Susan Jackson, et al.. (2021). Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma. Cancers. 13(24). 6342–6342. 6 indexed citations

Lelliott, Emily J., Stefano Mangiola, Kelly M. Ramsbottom, et al.. (2020). Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma. Cancer Immunology Research. 9(2). 136–146. 15 indexed citations

Cullinane, Carleen, Kelly Waldeck, Laura Kirby, et al.. (2020). Enhancing the anti-tumour activity of 177Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP. Scientific Reports. 10(1). 10196–10196. 63 indexed citations

Lelliott, Emily J., Carleen Cullinane, Claire Martin, et al.. (2019). A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy. Scientific Reports. 9(1). 1225–1225. 17 indexed citations

Martin, Claire, Carleen Cullinane, Laura Kirby, et al.. (2017). Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance. International Journal of Cancer. 142(10). 2139–2152. 54 indexed citations

Sheppard, Karen E., Carleen Cullinane, Claire Martin, et al.. (2016). Abstract 2826: Sustained melanoma regression is achieved with continuous palbociclib and PLX4720 treatment but not with intermittent or sequential dosing. Cancer Research. 76(14_Supplement). 2826–2826. 2 indexed citations

Young, Richard J., Kelly Waldeck, Claire Martin, et al.. (2014). Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines. Pigment Cell & Melanoma Research. 27(4). 590–600. 154 indexed citations

10.

Denoyer, Delphine, Laura Kirby, Kelly Waldeck, et al.. (2011). Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer. European Journal of Nuclear Medicine and Molecular Imaging. 39(4). 703–712. 8 indexed citations

11.

Denoyer, Delphine, Peter Roselt, Oliver Neels, et al.. (2010). Improved Detection of Regional Melanoma Metastasis Using ¹⁸F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-Specific PET Probe, by Perilesional Administration. Journal of Nuclear Medicine. 52(1). 115–122. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact